QC
IMCR icon

Quadrature Capital’s Immunocore IMCR Stock Holding History

Quadrature Capital’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.35M Buy
73,928
+54,674
+284% +$1.62M 0.02% 461
2026
Q1 		$581K Sell
19,254
-19,354
-50% -$626K 0.01% 736
2025
Q4 		$1.34M Buy
38,608
+19,595
+103% +$692K 0.01% 454
2025
Q3 		$690K Buy
19,013
+4,038
+27% +$137K 0.01% 442
2025
Q2 		$471K Buy
+14,975
New +$465K 0.01% 586

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Quadrature Capital's IMCR Position: Q2 2026 in Review

Quadrature Capital increased its Immunocore (IMCR) stake by 284% in Q2 2026, buying an estimated $1.62M and bringing the position to 73,928 shares worth $2.35M. The position accounts for 0.02% of the portfolio, ranked #461.

Quadrature Capital first reported a position in IMCR in Q2 2025 and has held it in 5 quarters since. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Quadrature Capital held 73,928 shares of Immunocore worth $2.35M as of Q2 2026.
  • Quadrature Capital bought 54,674 Immunocore shares in Q2 2026, an estimated $1.62M.
  • Immunocore made up 0.02% of Quadrature Capital's portfolio in Q2 2026, its #461 holding.
  • Quadrature Capital first reported a position in Immunocore in Q2 2025 and has held it in 5 quarters since.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.